To amend the Public Health Service Act to prohibit treatment of a biologic as a biological product based solely on the presence of a protein that is a clinically inactive component in such biologic, and for other purposes.

5/1/2026, 8:09 AM

Summary of Bill HR 8630

The bill "To amend the Public Health Service Act to prohibit treatment of a biologic as a biological product based solely on the presence of a protein that is a clinically inactive component in such biologic, and for other purposes" was introduced in the 119th Congress as H.R. 8630 on April 30, 2026.

Current Status of Bill HR 8630

Bill HR 8630 is currently in the status of Bill Introduced since April 30, 2026. Bill HR 8630 was introduced during Congress 119 and was introduced to the House on April 30, 2026. Bill HR 8630's most recent activity was Referred to the House Committee on Energy and Commerce. as of April 30, 2026

Bipartisan Support of Bill HR 8630

Total Number of Sponsors

Democrat Sponsors

Republican Sponsors

Unaffiliated Sponsors

Total Number of Cosponsors

Democrat Cosponsors

Republican Cosponsors

Unaffiliated Cosponsors

Policy Area and Potential Impact of Bill HR 8630

Primary Policy Focus

Alternate Title(s) of Bill HR 8630

To amend the Public Health Service Act to prohibit treatment of a biologic as a biological product based solely on the presence of a protein that is a clinically inactive component in such biologic, and for other purposes.